Interaction of Sulfonylureas with Liver Uptake Transporters OATP1B1 and OATP1B3
Author:
Affiliation:
1. Clinical Pharmacology Institute; Nanchang University; Nanchang China
2. Jiangxi Provincial Children's Hospital; Nanchang China
Funder
National Natural Science Foundation of China
Jiangxi Province Young Scientist Supporting Project
Publisher
Wiley
Subject
Pharmacology,Toxicology,General Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/bcpt.12992/fullpdf
Reference37 articles.
1. The current drug treatment landscape for diabetes and perspectives for the future;Bailey;Clin Pharmacol Ther,2015
2. Oral antidiabetic agents: current role in type 2 diabetes mellitus;Krentz;Drugs,2005
3. Inhibition of dipeptidyl peptidase-4 reduces glycemia, sustains insulin levels, and reduces glucagon levels in type 2 diabetes;Ahrén;J Clin Endocrinol Metab,2004
4. Sitagliptin. Dipeptidylpeptidase 4 inhibitor for patients with diabetes mellitus type 2;Musch;Med Monatsschr Pharm,2007
5. Comparative tolerability profiles of oral antidiabetic agents;Krentz;Drug Saf,1994
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Identification and characterization of endogenous biomarkers for hepatic vectorial transport (OATP1B3-P-gp) function using metabolomics with serum pharmacology;Amino Acids;2024-02-06
2. When the same treatment has different response: The role of pharmacogenomics in statin therapy;Biomedicine & Pharmacotherapy;2024-01
3. Investigation of drug-polymer miscibility and design of ternary solid dispersions for oral bioavailability enhancement by Hot Melt Extrusion;Journal of Drug Delivery Science and Technology;2023-12
4. Effects of CYP2C9 and CYP2C19 genetic polymorphisms on the pharmacokinetics and pharmacodynamics of gliclazide in healthy subjects;Archives of Pharmacal Research;2023-04-25
5. Mitochondrion-Targeted NIR Therapeutic Agent Suppresses Melanoma by Inducing Apoptosis and Cell Cycle Arrest via E2F/Cyclin/CDK Pathway;Pharmaceuticals;2022-12-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3